Pomerantz LLP

Company

Last mentioned: Mar 26, 2026

Timeline

  1. Discovery Phase

    Expected commencement of the discovery process if the cases survive initial motions to dismiss.

  2. Lead Plaintiff Deadline

    Estimated deadline for shareholders to petition the court to lead the litigation.

  3. Lead Plaintiff Deadline

    Final date for investors to apply for lead plaintiff status in the litigation.

  4. Lead Plaintiff Deadline (Est)

    Anticipated deadline for shareholders to move the court for lead plaintiff appointment.

  5. Secondary Notice

    Pomerantz reinforces the filing highlights to ensure broad investor awareness.

  6. Initial Legal Notice

    Pomerantz LLP issues the first public call for shareholders to join the class action.

  7. Legal Reminders Issued

    Pomerantz LLP issues formal reminders to shareholders of MREO and RR regarding active litigation.

  8. Enphase Suit Filed

    Pomerantz LLP files class action litigation against Enphase Energy in federal court.

  9. Legal Alerts

    Pomerantz LLP issues shareholder alerts for Driven Brands, CWH, and Apollo.

  10. Snowflake Filing

    Pomerantz LLP issues formal notice of class action filing against Snowflake Inc.

  11. Trip.com Filing

    Pomerantz LLP issues formal notice of class action filing against Trip.com Group Limited.

  12. Gartner Filing

    Pomerantz LLP issues formal notice of class action filing against Gartner, Inc.

  13. Public Notice

    Pomerantz LLP issues a formal notice to investors regarding the class action and lead plaintiff deadline.

  14. Litigation Launch

    Pomerantz LLP officially announces class action litigation against Nektar Therapeutics.

  15. Pomerantz LLP Action

    Pomerantz LLP formally advises shareholders of the class action filing.

  16. Lawsuit Filed

    Pomerantz Law Firm announces the filing of a class action against Gemini Space Station, Inc.

  17. Nektar Financial Update

    Nektar files updated results of operations and financial condition reports.

  18. Initial Lawsuit Alerts

    BFA Law issues alerts regarding manufacturing issues and securities fraud.

  19. Public Notice

    Formal notice of the class action is disseminated to potential class members and the public.

  20. Litigation Commencement

    Pomerantz LLP announces the filing of a class action lawsuit on behalf of shareholders.

Stories mentioning Pomerantz LLP 9

Corporate Law Neutral

Pomerantz LLP Initiates Securities Class Action Against Boston Scientific

Pomerantz LLP has issued a formal notice regarding a class action lawsuit against Boston Scientific Corporation (BSX), alleging potential securities fraud. The litigation focuses on whether the medical technology giant made misleading statements regarding its product pipeline or regulatory compliance during the class period.

2 sources
Corporate Law Neutral

Pomerantz LLP Targets Mereo BioPharma and Richtech Robotics in Class Actions

Pomerantz LLP has issued formal reminders regarding class action lawsuits filed against Mereo BioPharma and Richtech Robotics, signaling a surge in securities litigation within the biotech and automation sectors. These legal actions focus on alleged violations of federal securities laws, specifically regarding material misstatements that impacted investor valuations.

2 sources
Corporate Law Neutral

Eos Energy Faces Securities Fraud Litigation Amid Manufacturing Failures

Eos Energy (EOSE) is facing a significant class action lawsuit led by Pomerantz LLP following a 39% stock collapse and allegations of undisclosed manufacturing issues. The litigation centers on claims that the energy storage company misled investors regarding its operational scaling and financial forecasting accuracy.

2 sources
Regulation Bearish

Pomerantz Law Firm Files Class Action Against Gemini Space Station, Inc.

Pomerantz LLP has filed a class action lawsuit against Gemini Space Station, Inc. (GEMI) and certain officers, alleging securities fraud or other unlawful business practices. The suit, filed in the United States District Court, seeks to recover damages for investors who purchased GEMI securities during the specified class period.

2 sources

About Pomerantz LLP coverage

This page surfaces every story mentioning Pomerantz LLP across our legal coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.

Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running legal beat. Cross-entity comparisons live on our compare view.

What you seeWhat it tells you
Story countNumber of distinct stories where Pomerantz LLP was a primary or referenced actor.
Recency clusteringWhether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc).
Sentiment distributionAggregate sentiment of the stories mentioning this entity, weighted by impact score.
Cross-niche linksWhen the same entity surfaces in our sibling networks, we link to those views to enrich context.